Trials / Active Not Recruiting
Active Not RecruitingNCT07229820
Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A
A Randomized, Double-blind Phase III Clinical Study of ZSP1273 Tablets Compared With Placebo in Children 12-17 Years Old With Acute Uncomplicated Influenza A
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 157 (actual)
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZSP1273 | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2025-11-08
- Primary completion
- 2025-12-22
- Completion
- 2025-12-31
- First posted
- 2025-11-17
- Last updated
- 2025-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07229820. Inclusion in this directory is not an endorsement.